PapersPMID:23804546
Antiobesity effect of Gynostemma pentaphyllum extract (actiponin): a randomized, double-blind, placebo-controlled trial.
- findings
- 4
- compound
- 1
- endpoints
- 4
- Study, every finding
- RCT · 3 months
- Dose studied, every finding
- 450 mg per day
- Population, every finding
- Obese Korean adults without any diagnosed disease (BMI of 25 kg/m2 or more and waist-hip ratio of 0.90 or more for men, 0.85 or more for women)
What moved
How to read these marks →“During 12-week of actiponin supplementation, total abdominal fat area, body weight, body fat mass, percent body fat, and BMI were significantly decreased (P = 0.044, P < 0.05, P < 0.0001, P < 0.0001, and P < 0.05, respectively) in the actiponin group compared to the placebo group.”
- Decreases body mass
very limited
- Decreases fat mass
very limited
- Decreases body fat percentage (percent body fat)
very limited
- Decreases body mass index
very limited
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Obese Korean adults (BMI 25 or more and elevated waist-hip ratio) not diagnosed with any disease; actiponin, a heat-processed Gynostemma pentaphyllum extract. Abstract only, no full text
- Participants
- 80
- Comparator
- placebo
- Duration
- 84 days
- Endpoints measured
- 6